Search
Velsecorat
go.drugbank.com/drugs/DB16347InvestigationalVelsecorat is under investigation in clinical trial NCT02479412 (A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients
Ibuzatrelvir
go.drugbank.com/drugs/DB19451InvestigationalIbuzatrelvir is under investigation in clinical trial NCT06679140 (A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized but
Nelutroctiv
go.drugbank.com/drugs/DB21554InvestigationalNelutroctiv is under investigation in clinical trial NCT05662215 (A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants).
TAS-102
go.drugbank.com/drugs/DB08937InvestigationalTAS-102 (Taiho Pharma USA, Inc.) is an anti-cancer drug under development and in stage 3 clinical trials for the treatment of colorectal cancer.
Candoxatrilat
go.drugbank.com/drugs/DB11623ExperimentalA potent inhibitor of neutral endopeptidase (NEP, neprilysin, EC 3.4.24.11), it is used as its 2,3-dihydro-1H-inden-5-yl ester prodrug in the treatment of chronic heart failure.
Pumosetrag
go.drugbank.com/drugs/DB12402InvestigationalPumosetrag has been used in trials studying Gastroesophageal Reflux Disease.
Clinofibrate
go.drugbank.com/drugs/DB09006ExperimentalClinofibrate is a fibrate drug sold and marketed in Japan.
Hemoglobin crosfumaril
go.drugbank.com/drugs/DB13864ExperimentalHemoglobin in which the alpha-subunit are cross-linked intramolecularly.
Synonyms: Hemoglobin A0 (human alpha2 beta2 tetrameric subunit), alpha-chain 99,99'-diamide with (E)-2-butenoic acidDiclofop-methyl
go.drugbank.com/drugs/DB13918ExperimentalHerbicide for control of wild oat & foxtails in cereal crops.
Azintuxizumab vedotin
go.drugbank.com/drugs/DB14847InvestigationalAzintuxizumab vedotin is under investigation in clinical trial NCT02951117 (A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer … Has Come Back or Had No Response to Recent Cancer Treatment).